Skip to Main Content

Author Details

Eric Tse
School of Clinical Medicine, University of Hong Kong
1997
150
42
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36795237Expert consensus on the management of chronic lymphocytic leukaemia in Asia.Clin Exp Med2023
37845755Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.Exp Hematol Oncol2023
37945741The p97/VCP adaptor UBXD1 drives AAA+ remodeling and ring opening through multi-domain tethered interactions.Nat Struct Mol Biol2023
38033506Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.EClinicalMedicine2023
37236970Stacked binding of a PET ligand to Alzheimer's tau paired helical filaments.Nat Commun2023
37329451Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.Ann Hematol2023
37293102Asymmetric apical domain states of mitochondrial Hsp60 coordinate substrate engagement and chaperonin assembly.bioRxiv2023
37292947The p97/VCP adapter UBXD1 drives AAA+ remodeling and ring opening through multi-domain tethered interactions.bioRxiv2023
37259880Asia-Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region.Asia Pac J Clin Oncol2023
3656567736-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.Thromb Res2023
34757467Epstein-Barr virus-positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma.Ann Hematol2022
35544671Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections.Hematology2022
35666668Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment.Hematology2022
35628480Epigenetic Silencing of <i>PTEN</i> and Epi-Transcriptional Silencing of <i>MDM2</i> Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents.Int J Mol Sci2022
35659326How we treat NK/T-cell lymphomas.J Hematol Oncol2022
36805888Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.Semin Hematol2022
35869170Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria.Ann Hematol2022
35158865Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.Cancers (Basel)2022
34920389Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].Thromb Res2022
34767056Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre.Ann Hematol2022
34767055Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.Ann Hematol2022
34031651CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.Res Sq2021
33686199Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.Leukemia2021
33652328Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.Thromb Res2021
34380015The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state.Mol Cell2021
34661159Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins.Blood Cancer Discov2021
34476069Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin.Chem Sci2021
34013269CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.bioRxiv2021
34121173Arsenic trioxide inhibits anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma through targeting ALK-fusion oncoprotein.Br J Haematol2021
32365228Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.Cancer2020
32010690Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma.Front Cell Dev Biol2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33112933Rapid deployment of SARS-CoV-2 testing: The CLIAHUB.PLoS Pathog2020
32786092Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting.Hematol Oncol2020
32753688Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.Leukemia2020
32313240Conformational plasticity of the ClpAP AAA+ protease couples protein unfolding and proteolysis.Nat Struct Mol Biol2020
32249620Risk assessment of venous thromboembolism in hematological cancer patients: a review.Expert Rev Hematol2020
30663178Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.Respirology2019
31533964Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity.Life Sci Alliance2019
31585625NK/T-cell lymphomas.Best Pract Res Clin Haematol2019
31578281Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation.J Biol Chem2019
31346688Low-dose nivolumab induced durable complete response in relapsed primary central nervous system diffuse large B cell lymphoma.Ann Hematol2019
31487202Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.Expert Rev Hematol2019
30737390Chaperone activation and client binding of a 2-cysteine peroxiredoxin.Nat Commun2019
31160557Structural basis for substrate gripping and translocation by the ClpB AAA+ disaggregase.Nat Commun2019
28581364Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma.Hematology2018
30080396Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells.Anal Chem2018
30130556Polyphosphate Stabilizes Protein Unfolding Intermediates as Soluble Amyloid-like Oligomers.J Mol Biol2018
30534074PIN1 in Cell Cycle Control and Cancer.Front Pharmacol2018
30385828Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau.Nat Commun2018
  • 1 - 50 of 150

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
School of Clinical Sciences at Monash Health, Monash University
Career Start Year 2011
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 1
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2007
Number of shared co-authors 0
University of California san francisco
Career Start Year 2006
Number of shared co-authors 5
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2005
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Merck & Co.
Career Start Year 1998
Number of shared co-authors 2
Center for Lymphoid Malignancies, Columbia University Medical Center
Career Start Year 1997
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 2
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 1
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 21
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 2
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 0
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 3
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 5
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 1

Collaborators

The Institute for Neurodegenerative Diseases, University of California San Francisco
Co-authored papers 21
Co-authored papers 8
Institute for Neurodegenerative Diseases, University of California San Francisco
Co-authored papers 7
University of California san francisco
Co-authored papers 5
University of California san francisco
Co-authored papers 4
Tuen Mun Hospital
Co-authored papers 4
University of California san francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Fred Hutchinson Cancer Center
Co-authored papers 4
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
College of Chemistry, Jilin University
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco (UCSF) School of Medicine
Co-authored papers 3
Shanghai Clinical Research and Trial Center
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3